Abstract
Background: Stable angina is a debilitating and progressive disease caused by narrowing of the coronary arteries, which in turn affects cardiac perfusion. Statins have a well-established role, modifying symptoms and progression of the disease not only through lipid lowering, but also through pleiotropic effects.
Objective: We sought to evaluate the effect of statins in stable angina pectoris
Method: We performed a systematic review of the literature searching MEDLINE via Pubmed for all studies which examine the possible effects of statins in stable angina pectoris.
Results: Statins have demonstrated favourable modification of both biochemical markers (oxidative stress, inflammatory and coagulation markers/factors) and clinical symptoms (anginal and ischemic) of the disease. These effects have been demonstrated in vitro, ex vivo and in vivo in animals and humans, independently of the lipid lowering effects.
Conclusion: With an excellent safety profile and evidence of efficacy in managing patients with stable angina, statins appear an essential part of the therapeutic armoury against atherosclerotic disease.
Keywords: Stable angina, statins, atherosclerosis, ischaemia, pleiotropic effects, coronary arteries.
Current Pharmaceutical Design
Title:Statins in Stable Angina Pectoris
Volume: 23 Issue: 46
Author(s): Adam Ioannou, Nikolaos Papageorgiou*, Vincent McCaughan, Marietta Charakida, Dimitris Bertsias, Fay Zacharia, Gerasimos Siasos, George Latsios, Spyridon Papaioannou, Evangelos Oikonomou and Dimitris Tousoulis
Affiliation:
- Barts Heart Centre, St Bartholomew's Hospital, London,United Kingdom
Keywords: Stable angina, statins, atherosclerosis, ischaemia, pleiotropic effects, coronary arteries.
Abstract: Background: Stable angina is a debilitating and progressive disease caused by narrowing of the coronary arteries, which in turn affects cardiac perfusion. Statins have a well-established role, modifying symptoms and progression of the disease not only through lipid lowering, but also through pleiotropic effects.
Objective: We sought to evaluate the effect of statins in stable angina pectoris
Method: We performed a systematic review of the literature searching MEDLINE via Pubmed for all studies which examine the possible effects of statins in stable angina pectoris.
Results: Statins have demonstrated favourable modification of both biochemical markers (oxidative stress, inflammatory and coagulation markers/factors) and clinical symptoms (anginal and ischemic) of the disease. These effects have been demonstrated in vitro, ex vivo and in vivo in animals and humans, independently of the lipid lowering effects.
Conclusion: With an excellent safety profile and evidence of efficacy in managing patients with stable angina, statins appear an essential part of the therapeutic armoury against atherosclerotic disease.
Export Options
About this article
Cite this article as:
Ioannou Adam , Papageorgiou Nikolaos *, McCaughan Vincent , Charakida Marietta, Bertsias Dimitris, Zacharia Fay , Siasos Gerasimos, Latsios George , Papaioannou Spyridon, Oikonomou Evangelos and Tousoulis Dimitris , Statins in Stable Angina Pectoris, Current Pharmaceutical Design 2017; 23 (46) . https://dx.doi.org/10.2174/1381612823666170828132303
| DOI https://dx.doi.org/10.2174/1381612823666170828132303 |
Print ISSN 1381-6128 |
| Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
Accelerating Cancer Drug Discovery Using Artificial Intelligence and In Silico Methods
Artificial intelligence and in silico methods speed up cancer drug discovery, transforming how new treatments are developed. Artificial intelligence, along with in silico methods, allows for quick investigation of large biological datasets, helping identify potential drug targets with remarkable speed and accuracy. Machine learning models help us understand how molecules ...read more
Artificial Intelligence and Computational Approaches in Drug Discovery
Computer-aided drug design (CADD) and artificial intelligence (AI) are fundamentally reshaping drug discovery pipelines by significantly enhancing efficiency in molecular screening, rational drug design, and natural product development. In the field of molecular screening, the integration of virtual high-throughput screening with advanced AI models enables rapid analysis of million-compound libraries, ...read more
Artificial Intelligence for Transformative Healthcare: From Prediction to Prevention
Machine learning and deep learning are transforming biomedical diagnosis by allowing for quicker and more accurate disease detection, ultimately enhancing patient care. Using advanced algorithms and extensive medical data, these approaches uncover patterns that may not be visible to humans, resulting in better detection of conditions such as cancer and ...read more
Mapping Dynamic Sites and Designing Novel Therapeutics
The concept of allostery, where ligand binding at a site distinct from the active or orthosteric site modulates protein function, has emerged as a transformative paradigm in modern drug discovery. Unlike conventional orthosteric drugs that often face limitations in selectivity and off-target effects, allosteric modulators offer a promising alternative. Their ...read more
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
GPER and ER: Estrogen Receptors with Distinct Biological Roles in Breast Cancer
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) MicroRNAs: A Critical Regulator and a Promising Therapeutic and Diagnostic Molecule for Diabetic Cardiomyopathy
Current Gene Therapy Inflammatory Arthritis and Heart Disease
Current Pharmaceutical Design Blood Pressure Responses in Firefighters: A Review
Current Hypertension Reviews Hedgehog Signaling and Urological Cancers
Current Drug Targets Oxygen Sensing in Health and Disease
Current Respiratory Medicine Reviews Leptinaemia and Antiendothelial Antibodies in Accelerated Atherosclerosis – Is There a Relationship?
Vascular Disease Prevention (Discontinued) Bone Marrow Stem Cell Therapy for Myocardial Angiogenesis
Current Vascular Pharmacology Oxidative Stress as a Regulator of Murine Atherosclerosis
Current Drug Targets Direct and Indirect Measurement of Temporal Horn Volume and Temporal Horn Index and its Neuropsychological Correlation in Mild Cognitive Impaired and Alzheimer Diseased Patients
Current Medical Imaging Defensive and Offensive Cross-Reactive Antibodies Elicited by Pathogens: The Good, the Bad and the Ugly
Current Medicinal Chemistry Disease-Related Changes in TRPV1 Expression and Its Implications for Drug Development
Current Topics in Medicinal Chemistry Hypertensive Treatment and the Metabolic Syndrome
Current Hypertension Reviews Significant Correlation between Cystatin C, Cerebral Infarction, and Potential Biomarker for Increased Risk of Stroke
Current Neurovascular Research Mining the Genome for Susceptibility to Complex Neurological Disorders
Current Molecular Medicine Imaging Modalities in the Outcome Assessment of Knee Osteoarthritis
Current Rheumatology Reviews Perspective on ‘Phase V’ or Logistics and Regression as Logical Progression for Community Heart Failure Triage
Current Cardiology Reviews Digitalis-like Compounds: the Discovery of the O-aminoalkyloxime Group as a Very Powerful Substitute for the Unsaturated γ-Butyrolactone Moiety
Current Medicinal Chemistry Is the Evolutionary Programmed/ Non-programmed Aging Argument Moot?
Current Aging Science Gender Differences in the Effects of Angiotensin Receptor Blockers on Cardiovascular Disease
Current Pharmaceutical Design





